These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 22465097)

  • 41. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.
    Zheng HQ; Zhou Z; Huang J; Chaudhury L; Dong JT; Chen C
    Oncogene; 2009 Oct; 28(42):3702-13. PubMed ID: 19668233
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A short peptide derived from the gN helix domain of FGF8b suppresses the growth of human prostate cancer cells.
    Li T; Luo W; He D; Wang R; Huang Y; Zeng X; Wang W; Chen X; Gao S; Yu Y; Li X; Wu X
    Cancer Lett; 2013 Oct; 339(2):226-36. PubMed ID: 23774400
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rational combinations of siRNAs targeting Plk1 with breast cancer drugs.
    Spänkuch B; Kurunci-Csacsko E; Kaufmann M; Strebhardt K
    Oncogene; 2007 Aug; 26(39):5793-807. PubMed ID: 17369857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RNAi-mediated silencing of Anxa2 inhibits breast cancer cell proliferation by downregulating cyclin D1 in STAT3-dependent pathway.
    Zhang F; Wang Z; Yuan J; Wei X; Tian R; Niu R
    Breast Cancer Res Treat; 2015 Sep; 153(2):263-75. PubMed ID: 26253946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lentivirus-mediated shRNA interference targeting cyclooxygenase-2 inhibits growth of human non-small cell lung cancer.
    Li T; Lu J; Zhong Y
    J BUON; 2013; 18(4):908-14. PubMed ID: 24344016
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between expression of genes involved in cell cycle control and apoptosis in diffuse large B cell lymphoma: a preferential survivin-cyclin B link.
    Kuttler F; Valnet-Rabier MB; Angonin R; Ferrand C; Deconinck E; Mougin C; Cahn JY; Fest T
    Leukemia; 2002 Apr; 16(4):726-35. PubMed ID: 11960356
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Knockdown of interferon-induced transmembrane protein 3 expression suppresses breast cancer cell growth and colony formation and affects the cell cycle.
    Yang M; Gao H; Chen P; Jia J; Wu S
    Oncol Rep; 2013 Jul; 30(1):171-8. PubMed ID: 23624618
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MiR‑203 regulates the proliferation, apoptosis and cell cycle progression of pancreatic cancer cells by targeting Survivin.
    Xu D; Wang Q; An Y; Xu L
    Mol Med Rep; 2013 Aug; 8(2):379-84. PubMed ID: 23732815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin.
    Vanderlaag KE; Hudak S; Bald L; Fayadat-Dilman L; Sathe M; Grein J; Janatpour MJ
    Breast Cancer Res; 2010; 12(3):R32. PubMed ID: 20525379
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comprehensive analysis of differentially expressed genes associated with PLK1 in bladder cancer.
    Zhang Z; Zhang G; Gao Z; Li S; Li Z; Bi J; Liu X; Li Z; Kong C
    BMC Cancer; 2017 Dec; 17(1):861. PubMed ID: 29246203
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased expression of MDM2, cyclin D1, and p27Kip1 in carcinogen-induced rat mammary tumors.
    Murray SA; Yang S; Demicco E; Ying H; Sherr DH; Hafer LJ; Rogers AE; Sonenshein GE; Xiao ZX
    J Cell Biochem; 2005 Aug; 95(5):875-84. PubMed ID: 15844214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth.
    Izzo F; Mercogliano F; Venturutti L; Tkach M; Inurrigarro G; Schillaci R; Cerchietti L; Elizalde PV; Proietti CJ
    Breast Cancer Res; 2014 Dec; 16(6):491. PubMed ID: 25479686
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibroblast growth factor 8 induced downregulation of thrombospondin 1 is mediated by the MEK/ERK and PI3K pathways in breast cancer cells.
    Tarkkonen K; Ruohola J; Härkönen P
    Growth Factors; 2010 Aug; 28(4):256-67. PubMed ID: 20370578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Benzophenone-1 stimulated the growth of BG-1 ovarian cancer cells by cell cycle regulation via an estrogen receptor alpha-mediated signaling pathway in cellular and xenograft mouse models.
    Park MA; Hwang KA; Lee HR; Yi BR; Jeung EB; Choi KC
    Toxicology; 2013 Mar; 305():41-8. PubMed ID: 23328252
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PLK1 and YY1 interaction in follicular lymphoma is associated with unfavourable outcome.
    Sandison HE; Usher S; Karimiani EG; Ashton G; Menasce LP; Radford JA; Linton K; Byers RJ
    J Clin Pathol; 2013 Sep; 66(9):764-7. PubMed ID: 23757039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CHFR-associated early G2/M checkpoint defects in breast cancer cells.
    Erson AE; Petty EM
    Mol Carcinog; 2004 Jan; 39(1):26-33. PubMed ID: 14694445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Uptake of plasmid-loaded nanoparticles in breast cancer cells and effect on Plk1 expression.
    Steinhauser I; Langer K; Strebhardt K; Spänkuch B
    J Drug Target; 2009 Sep; 17(8):627-37. PubMed ID: 19591537
    [TBL] [Abstract][Full Text] [Related]  

  • 59. BRCA1-IRIS activates cyclin D1 expression in breast cancer cells by downregulating the JNK phosphatase DUSP3/VHR.
    Hao L; ElShamy WM
    Int J Cancer; 2007 Jul; 121(1):39-46. PubMed ID: 17278098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ZIC1 acts a tumor suppressor in breast cancer by targeting survivin.
    Han W; Cao F; Gao XJ; Wang HB; Chen F; Cai SJ; Zhang C; Hu YW; Ma J; Gu X; Ding HZ
    Int J Oncol; 2018 Sep; 53(3):937-948. PubMed ID: 29956756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.